Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gaymar is a healthcare technology company that specialized in the development and manufacture of temperature management and pressure relief systems. The company's product portfolio included advanced thermoregulation devices, such as the Medi-Therm hyper/hypothermia system, and specialized surfaces for the prevention of pressure ulcers. These solutions were primarily utilized in acute care settings, including operating rooms and intensive care units, to maintain patient normothermia and skin integrity. In 2010, Gaymar was acquired by Stryker Corporation for approximately $150 million. This acquisition allowed Stryker to integrate Gaymar's market-leading temperature management and pressure relief technologies into its Medical division. Today, Gaymar's legacy products continue to be a core part of Stryker's patient care and recovery offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gaymar Holding.